2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Pneumonia, Staphylococcal: new trials by email Literature Review of Pneumonia, Staphylococcal trials Research Report on Pneumonia, Staphylococcal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vancomycin Dosage Strategy Based on a Trough Concentration Model Individualized therapy - Pneumonia, Staphylococcal | Phase 4 | Completed | Peking University Third Hospital | 66 | 2019-10-01 | 2022-08-31 |
| Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA) linezolid (Zyvox), vancomycin - Methicillin Resistant Staphylococcus Aureus (MRSA) | Phase 4 | Completed | Pfizer | 1225 | 2004-10-01 | 2012-02-01 |
Healthcare-Associated Pneumonia (1) · Pneumonia (1)
Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Gram-Positive Bacterial Infections (2) · Infections (2) · Lung Diseases (2) · Pneumonia, Bacterial (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Staphylococcal Infections (2) · Cross Infection (1) · Disease Attributes (1) · Iatrogenic Disease (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pneumonia (1)
Vancomycin (2) · Linezolid (1)
Peking University Third Hospital (1) · Pfizer (1)
Argentina (1) · Belgium (1) · Brazil (1) · Chile (1) · China (1) · Colombia (1) · France (1) · Germany (1) · Greece (1) · Hong Kong (1) · Malaysia (1) · Mexico (1) · Poland (1) · Portugal (1) · Puerto Rico (1)